“Integrated Safety Analysis of Ruxolitinib Cream: Data From 20 Clinical Studies in Inflammatory Dermatologic Conditions”. 2025. SKIN The Journal of Cutaneous Medicine 9 (6): s711. https://doi.org/10.25251/36mxmk39.